Bioequivalence Study of Cephalexin Suspension 125
NCT01767532
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class
Conditions
Infections, Respiratory Tract
Interventions
DRUG:
Cephalexin 125 mg/5ml
DRUG:
Cephalexin 125 mg/5ml
Sponsor
GlaxoSmithKline